MaxCyte скачать в хорошем качестве

MaxCyte

Madhusudan Peshwa, Ph.D., Chief Scientific Officer Gaithersburg, MD (Private) MaxCyte is a U.S.-based global company dedicated to accelerating the discovery, development, manufacturing and commercialization of next-generation, cell-based medicines. The company provides its patented, high-performance cell engineering platform to biopharmaceutical partners engaged in drug discovery and development, biomanufacturing and cell therapy, including gene editing and immuno-oncology. With its robust delivery platform, MaxCyte’s team of scientific experts helps its partners to unlock their product potential and solve development and commercialization challenges. This platform allows for the engineering of nearly all cell types, including human primary cells, with any molecule, at any scale. It also provides unparalleled consistency and minimal cell disturbance, thereby facilitating rapid, large-scale, clinical and commercial grade, high-performance cell engineering in a non-viral system and with low-toxicity concerns. The company’s cell-engineering platform is CE-marked and FDA-accredited, providing MaxCyte’s customers and partners with an established regulatory path to commercialize cell-based medicines. www.maxcyte.com